Paul Coleman
Concepts (297)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Alzheimer Disease | 41 | 1986 | 72 |
Why?
| Aging | 27 | 1981 | 275 |
Why?
| Neurons | 24 | 1981 | 195 |
Why?
| Nerve Tissue Proteins | 18 | 1990 | 128 |
Why?
| Neurofibrillary Tangles | 13 | 1992 | 10 |
Why?
| Monomeric Clathrin Assembly Proteins | 6 | 1998 | 3 |
Why?
| Brain | 16 | 1986 | 305 |
Why?
| Hippocampus | 17 | 1986 | 83 |
Why?
| Synapses | 8 | 1994 | 49 |
Why?
| Phosphoproteins | 6 | 1993 | 86 |
Why?
| Synaptophysin | 4 | 1998 | 5 |
Why?
| Dendrites | 8 | 1985 | 24 |
Why?
| Synaptic Vesicles | 4 | 1998 | 1 |
Why?
| Cerebral Cortex | 5 | 1982 | 108 |
Why?
| Brain Chemistry | 3 | 1997 | 60 |
Why?
| Astrocytes | 7 | 1993 | 62 |
Why?
| Frontal Lobe | 3 | 1998 | 33 |
Why?
| Epigenesis, Genetic | 2 | 2008 | 11 |
Why?
| Prostaglandin-Endoperoxide Synthases | 4 | 1996 | 66 |
Why?
| RNA, Messenger | 12 | 1992 | 394 |
Why?
| Membrane Proteins | 7 | 1992 | 233 |
Why?
| Aged, 80 and over | 18 | 1986 | 602 |
Why?
| Humans | 54 | 1986 | 1858 |
Why?
| Neuroglia | 5 | 1990 | 49 |
Why?
| Twins, Monozygotic | 1 | 2009 | 28 |
Why?
| Aged | 25 | 1986 | 992 |
Why?
| Membrane Glycoproteins | 6 | 1990 | 154 |
Why?
| Nerve Degeneration | 4 | 1993 | 43 |
Why?
| Interleukin-1 | 3 | 1996 | 109 |
Why?
| Enzyme Inhibitors | 3 | 1998 | 216 |
Why?
| Animals | 39 | 1981 | 1032 |
Why?
| Microglia | 2 | 2003 | 29 |
Why?
| Isoenzymes | 4 | 1996 | 144 |
Why?
| Protein Transport | 3 | 2002 | 101 |
Why?
| Presynaptic Terminals | 2 | 2002 | 14 |
Why?
| Clinical Trials as Topic | 1 | 2010 | 251 |
Why?
| Gene Expression Profiling | 3 | 2003 | 138 |
Why?
| Rats | 22 | 1981 | 532 |
Why?
| Neuronal Plasticity | 5 | 1990 | 46 |
Why?
| Immunohistochemistry | 13 | 1993 | 356 |
Why?
| Neurofilament Proteins | 4 | 1994 | 18 |
Why?
| Facial Nerve Injuries | 1 | 2003 | 4 |
Why?
| Facial Nerve | 1 | 2003 | 6 |
Why?
| tau Proteins | 4 | 1997 | 15 |
Why?
| Middle Aged | 17 | 1986 | 1166 |
Why?
| Pons | 1 | 2003 | 17 |
Why?
| Axonal Transport | 1 | 2003 | 11 |
Why?
| Clathrin | 2 | 1998 | 8 |
Why?
| Basal Ganglia | 2 | 1985 | 23 |
Why?
| Acetylglucosamine | 2 | 1998 | 5 |
Why?
| Male | 25 | 1981 | 1558 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 243 |
Why?
| Gene Expression | 4 | 1992 | 291 |
Why?
| Adaptor Proteins, Vesicular Transport | 5 | 1998 | 9 |
Why?
| Rodentia | 2 | 1988 | 11 |
Why?
| Rats, Inbred F344 | 9 | 1981 | 80 |
Why?
| Chromatography, Thin Layer | 1 | 1999 | 25 |
Why?
| Electrophoresis | 1 | 1999 | 23 |
Why?
| Choline | 1 | 1999 | 24 |
Why?
| Cathepsin D | 1 | 1999 | 8 |
Why?
| DNA Methylation | 2 | 2008 | 29 |
Why?
| Cell Aging | 1 | 1999 | 31 |
Why?
| Second Messenger Systems | 1 | 1998 | 19 |
Why?
| Astrocytoma | 1 | 1998 | 26 |
Why?
| GAP-43 Protein | 6 | 1990 | 6 |
Why?
| Supraoptic Nucleus | 3 | 1985 | 8 |
Why?
| Huntington Disease | 1 | 1998 | 30 |
Why?
| Clinical Laboratory Techniques | 1 | 1997 | 31 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 38 |
Why?
| Cerebellar Cortex | 1 | 1996 | 7 |
Why?
| Tritium | 3 | 1998 | 65 |
Why?
| Female | 13 | 1992 | 1646 |
Why?
| RNA, Antisense | 3 | 1992 | 11 |
Why?
| Cytoskeleton | 1 | 1995 | 47 |
Why?
| Phosphorylation | 5 | 1993 | 224 |
Why?
| Ischemic Attack, Transient | 1 | 1994 | 28 |
Why?
| Blood Proteins | 1 | 1994 | 71 |
Why?
| Terminology as Topic | 2 | 1989 | 81 |
Why?
| In Situ Hybridization | 3 | 1994 | 135 |
Why?
| Neurons, Afferent | 1 | 1993 | 48 |
Why?
| Oligonucleotide Array Sequence Analysis | 3 | 2002 | 135 |
Why?
| Cerebellum | 3 | 1987 | 59 |
Why?
| Nervous System Diseases | 1 | 1993 | 78 |
Why?
| Prefrontal Cortex | 1 | 1992 | 13 |
Why?
| Parkinson Disease | 2 | 2004 | 67 |
Why?
| Cell Count | 6 | 1981 | 163 |
Why?
| Cyclooxygenase 2 | 4 | 1996 | 77 |
Why?
| Pyramidal Tracts | 1 | 1991 | 8 |
Why?
| Glial Fibrillary Acidic Protein | 4 | 1993 | 37 |
Why?
| Gene Expression Regulation | 3 | 2003 | 279 |
Why?
| Time Factors | 5 | 1993 | 896 |
Why?
| Mice | 8 | 1982 | 623 |
Why?
| Dentate Gyrus | 2 | 1998 | 20 |
Why?
| Cells, Cultured | 7 | 1996 | 447 |
Why?
| Cell Death | 3 | 1991 | 94 |
Why?
| Forecasting | 1 | 2010 | 148 |
Why?
| Models, Neurological | 1 | 1990 | 59 |
Why?
| Base Sequence | 5 | 1992 | 371 |
Why?
| Haplorhini | 1 | 1988 | 43 |
Why?
| Galactose | 2 | 1998 | 14 |
Why?
| Reference Values | 2 | 1999 | 281 |
Why?
| Rats, Sprague-Dawley | 7 | 1993 | 257 |
Why?
| Biological Markers | 1 | 2010 | 263 |
Why?
| Acetylcholine | 1 | 2007 | 49 |
Why?
| Proteome | 1 | 2007 | 26 |
Why?
| Valproic Acid | 1 | 2007 | 26 |
Why?
| Prosencephalon | 1 | 2007 | 29 |
Why?
| Molecular Sequence Data | 5 | 1992 | 404 |
Why?
| Chromatography, High Pressure Liquid | 2 | 1994 | 122 |
Why?
| Phenotype | 1 | 2009 | 304 |
Why?
| Dopamine | 1 | 2008 | 62 |
Why?
| Cyclooxygenase 2 Inhibitors | 2 | 1996 | 45 |
Why?
| Cyclooxygenase Inhibitors | 2 | 1996 | 47 |
Why?
| Somatosensory Cortex | 1 | 1986 | 24 |
Why?
| Leukocytes | 1 | 2007 | 94 |
Why?
| Synaptic Transmission | 2 | 2002 | 58 |
Why?
| Adult | 6 | 1986 | 1321 |
Why?
| Substantia Innominata | 1 | 1985 | 2 |
Why?
| Hypothalamus, Anterior | 1 | 1985 | 4 |
Why?
| Case-Control Studies | 2 | 1996 | 284 |
Why?
| Limbic System | 1 | 1985 | 15 |
Why?
| Presenilin-1 | 1 | 2004 | 6 |
Why?
| Amyloid beta-Protein Precursor | 1 | 2004 | 15 |
Why?
| Principal Component Analysis | 1 | 2004 | 19 |
Why?
| Individuality | 1 | 2004 | 9 |
Why?
| Pedigree | 1 | 2004 | 84 |
Why?
| Amino Acid Substitution | 1 | 2004 | 68 |
Why?
| Axotomy | 1 | 2003 | 3 |
Why?
| Dementia | 1 | 2004 | 56 |
Why?
| Dynamin I | 1 | 2003 | 2 |
Why?
| Models, Animal | 1 | 2004 | 85 |
Why?
| Immunoblotting | 3 | 1995 | 120 |
Why?
| Point Mutation | 1 | 2004 | 122 |
Why?
| Azo Compounds | 1 | 2003 | 15 |
Why?
| Cell Survival | 2 | 1990 | 230 |
Why?
| Cognition | 1 | 2004 | 98 |
Why?
| Synaptic Membranes | 1 | 2002 | 4 |
Why?
| DNA Mutational Analysis | 1 | 2003 | 110 |
Why?
| DNA Primers | 1 | 2004 | 208 |
Why?
| Blood-Brain Barrier | 1 | 2003 | 63 |
Why?
| Nucleic Acid Amplification Techniques | 1 | 2002 | 10 |
Why?
| Multivariate Analysis | 1 | 2004 | 227 |
Why?
| Signal Transduction | 2 | 1990 | 313 |
Why?
| Serine | 1 | 2002 | 62 |
Why?
| Nerve Regeneration | 1 | 2002 | 29 |
Why?
| Neurodegenerative Diseases | 1 | 2002 | 30 |
Why?
| Lipopolysaccharides | 2 | 1996 | 98 |
Why?
| Locus Coeruleus | 1 | 1981 | 13 |
Why?
| Antibodies | 1 | 2002 | 159 |
Why?
| Disease Models, Animal | 2 | 1993 | 349 |
Why?
| Molecular Weight | 2 | 1996 | 155 |
Why?
| Sensitivity and Specificity | 1 | 2004 | 427 |
Why?
| Organ Specificity | 1 | 2000 | 104 |
Why?
| Retina | 1 | 2002 | 61 |
Why?
| Age Factors | 1 | 2004 | 480 |
Why?
| Fibroblast Growth Factor 2 | 2 | 1996 | 49 |
Why?
| Histocytochemistry | 2 | 1985 | 65 |
Why?
| Choline Kinase | 1 | 1999 | 2 |
Why?
| Phosphorylcholine | 1 | 1999 | 11 |
Why?
| Blotting, Northern | 3 | 1992 | 152 |
Why?
| Solubility | 1 | 1999 | 76 |
Why?
| Mice, Inbred C3H | 2 | 1996 | 86 |
Why?
| Calmodulin-Binding Proteins | 1 | 1998 | 9 |
Why?
| Water | 1 | 1999 | 85 |
Why?
| Cell Nucleolus | 2 | 1981 | 13 |
Why?
| Chromosomes, Human, Pair 21 | 1 | 1998 | 7 |
Why?
| Glycosylation | 1 | 1998 | 37 |
Why?
| Oligonucleotide Probes | 1 | 1998 | 40 |
Why?
| Galactosyltransferases | 1 | 1998 | 4 |
Why?
| Down Syndrome | 1 | 1998 | 29 |
Why?
| Oligosaccharides | 1 | 1998 | 19 |
Why?
| Precipitin Tests | 1 | 1998 | 81 |
Why?
| Sphingomyelin Phosphodiesterase | 1 | 1998 | 9 |
Why?
| Ovalbumin | 1 | 1998 | 32 |
Why?
| Linear Models | 1 | 1999 | 151 |
Why?
| Phosphatidylcholines | 1 | 1998 | 28 |
Why?
| Carrier Proteins | 1 | 2002 | 177 |
Why?
| Acetylation | 1 | 1998 | 46 |
Why?
| Chromosome Mapping | 1 | 1998 | 107 |
Why?
| Neocortex | 1 | 1997 | 12 |
Why?
| Type C Phospholipases | 1 | 1998 | 34 |
Why?
| Gyrus Cinguli | 1 | 1997 | 5 |
Why?
| Culture Media | 1 | 1997 | 116 |
Why?
| Fetus | 1 | 1998 | 105 |
Why?
| Disease Progression | 1 | 1999 | 244 |
Why?
| Amino Acid Sequence | 3 | 1993 | 319 |
Why?
| Phorbol Esters | 1 | 1996 | 12 |
Why?
| Nitrobenzenes | 1 | 1996 | 20 |
Why?
| Mutation | 1 | 2003 | 340 |
Why?
| Biopsy | 1 | 1997 | 208 |
Why?
| Protein Kinase C | 1 | 1998 | 93 |
Why?
| Epilepsy | 1 | 1997 | 49 |
Why?
| Enzyme Induction | 1 | 1996 | 64 |
Why?
| Temporal Lobe | 1 | 1997 | 41 |
Why?
| Research | 1 | 1997 | 125 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 1996 | 210 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1996 | 83 |
Why?
| Photoreceptor Cells | 1 | 1995 | 13 |
Why?
| Enzyme Activation | 1 | 1998 | 177 |
Why?
| Cell Line | 1 | 2000 | 375 |
Why?
| Retinal Degeneration | 1 | 1995 | 16 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1997 | 78 |
Why?
| Sulfonamides | 1 | 1996 | 74 |
Why?
| Dexamethasone | 1 | 1996 | 109 |
Why?
| Cell Division | 1 | 1998 | 273 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 1997 | 104 |
Why?
| Tumor Cells, Cultured | 1 | 1998 | 233 |
Why?
| Blotting, Western | 1 | 1997 | 275 |
Why?
| Mice, Inbred C57BL | 3 | 1982 | 318 |
Why?
| Transcription, Genetic | 2 | 1993 | 253 |
Why?
| Animals, Newborn | 1 | 1996 | 175 |
Why?
| Nerve Endings | 1 | 1993 | 12 |
Why?
| Pyramidal Cells | 1 | 1994 | 14 |
Why?
| Genes, Homeobox | 1 | 1993 | 20 |
Why?
| Hypothalamus | 1 | 1993 | 33 |
Why?
| Staining and Labeling | 1 | 1993 | 101 |
Why?
| Neurites | 1 | 1992 | 15 |
Why?
| Poly A | 1 | 1992 | 17 |
Why?
| Cytokines | 1 | 1997 | 207 |
Why?
| DNA Probes | 1 | 1992 | 61 |
Why?
| Down-Regulation | 2 | 1996 | 150 |
Why?
| Connexins | 1 | 1992 | 18 |
Why?
| DNA-Directed RNA Polymerases | 1 | 1992 | 21 |
Why?
| Prognosis | 1 | 1995 | 389 |
Why?
| Peptide Fragments | 1 | 1994 | 145 |
Why?
| Brain Ischemia | 1 | 1993 | 45 |
Why?
| Polymerase Chain Reaction | 1 | 1994 | 279 |
Why?
| Oligodeoxyribonucleotides | 1 | 1992 | 86 |
Why?
| Viral Proteins | 1 | 1992 | 71 |
Why?
| Growth Substances | 1 | 1991 | 51 |
Why?
| Adolescent | 2 | 1994 | 892 |
Why?
| DNA | 2 | 1992 | 263 |
Why?
| Genomic Instability | 1 | 2008 | 12 |
Why?
| Cell Communication | 1 | 1990 | 72 |
Why?
| Microscopy, Electron | 2 | 1995 | 178 |
Why?
| Cell Compartmentation | 2 | 1993 | 37 |
Why?
| Gender Identity | 1 | 2008 | 18 |
Why?
| Genetic Markers | 1 | 2008 | 78 |
Why?
| Axons | 1 | 1990 | 67 |
Why?
| RNA | 1 | 1992 | 126 |
Why?
| Spiperone | 1 | 2008 | 5 |
Why?
| Receptors, Dopamine | 1 | 2008 | 16 |
Why?
| Dopamine Antagonists | 1 | 2008 | 11 |
Why?
| Child | 1 | 1997 | 750 |
Why?
| Brain-Derived Neurotrophic Factor | 1 | 2008 | 16 |
Why?
| Coculture Techniques | 1 | 2008 | 59 |
Why?
| Neuroblastoma | 1 | 2008 | 36 |
Why?
| Sex Characteristics | 1 | 2008 | 86 |
Why?
| Tretinoin | 1 | 2008 | 48 |
Why?
| Amygdala | 1 | 1987 | 12 |
Why?
| Potassium | 1 | 2008 | 98 |
Why?
| Species Specificity | 1 | 1987 | 186 |
Why?
| Sympathetic Nervous System | 1 | 1987 | 43 |
Why?
| Golgi Apparatus | 1 | 1986 | 26 |
Why?
| Anticonvulsants | 1 | 2007 | 61 |
Why?
| Spleen | 1 | 1987 | 129 |
Why?
| Up-Regulation | 1 | 2007 | 183 |
Why?
| Preoptic Area | 1 | 1985 | 6 |
Why?
| Septal Nuclei | 1 | 1985 | 4 |
Why?
| Cholinergic Fibers | 1 | 1985 | 8 |
Why?
| Acetylcholinesterase | 1 | 1985 | 13 |
Why?
| Cloning, Molecular | 2 | 1993 | 183 |
Why?
| Receptors, Notch | 1 | 2004 | 30 |
Why?
| Hair Removal | 1 | 1982 | 3 |
Why?
| Adaptor Protein Complex 2 | 1 | 2002 | 1 |
Why?
| Macaca fascicularis | 1 | 2002 | 36 |
Why?
| Antineoplastic Agents | 1 | 2008 | 191 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 2001 | 42 |
Why?
| Exocytosis | 1 | 2002 | 15 |
Why?
| Dopamine beta-Hydroxylase | 1 | 1981 | 8 |
Why?
| Cell Nucleus | 1 | 1982 | 169 |
Why?
| Bombyx | 1 | 1998 | 5 |
Why?
| Entorhinal Cortex | 1 | 1998 | 6 |
Why?
| Recombinant Proteins | 1 | 2001 | 290 |
Why?
| Animals, Genetically Modified | 1 | 1998 | 29 |
Why?
| Stem Cells | 1 | 2002 | 107 |
Why?
| Embryonic and Fetal Development | 1 | 1998 | 52 |
Why?
| Autopsy | 1 | 1997 | 50 |
Why?
| Epitopes | 1 | 1998 | 87 |
Why?
| Feasibility Studies | 1 | 1997 | 144 |
Why?
| Models, Biological | 1 | 1982 | 411 |
Why?
| Phosphopyruvate Hydratase | 1 | 1996 | 24 |
Why?
| Nucleic Acid Hybridization | 1 | 1996 | 94 |
Why?
| Binding Sites | 1 | 1998 | 213 |
Why?
| Stereotaxic Techniques | 1 | 1995 | 24 |
Why?
| Protein Binding | 1 | 1998 | 256 |
Why?
| Trans-Activators | 1 | 1998 | 113 |
Why?
| Cytosol | 1 | 1993 | 79 |
Why?
| Antibodies, Monoclonal | 1 | 1998 | 242 |
Why?
| Longitudinal Studies | 1 | 1994 | 195 |
Why?
| Sequence Alignment | 1 | 1993 | 114 |
Why?
| Sequence Homology, Amino Acid | 1 | 1993 | 156 |
Why?
| Cross-Sectional Studies | 1 | 1995 | 254 |
Why?
| Cell Differentiation | 1 | 1998 | 262 |
Why?
| Cell Membrane | 1 | 1993 | 170 |
Why?
| Norepinephrine | 1 | 1987 | 68 |
Why?
| Microscopy, Fluorescence | 1 | 1987 | 138 |
Why?
|
|
Coleman's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
